Compare CYRX & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | TCPC |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 407.2M |
| IPO Year | 2008 | 2006 |
| Metric | CYRX | TCPC |
|---|---|---|
| Price | $10.32 | $4.33 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $13.31 | $3.50 |
| AVG Volume (30 Days) | 388.4K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 17.93% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | $7.26 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $3.43 |
| 52 Week High | $11.45 | $8.05 |
| Indicator | CYRX | TCPC |
|---|---|---|
| Relative Strength Index (RSI) | 74.32 | 65.65 |
| Support Level | $9.18 | $3.43 |
| Resistance Level | $11.33 | $5.99 |
| Average True Range (ATR) | 0.40 | 0.16 |
| MACD | 0.17 | 0.11 |
| Stochastic Oscillator | 93.26 | 85.38 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.